Best of Oncology Podcast Series

263 Episodes

1. Best Of ASCO® Vancouver 2024: Non-Prostate GU Cancer – Dr. Christian Kollmannsberger

   Published: 2/07/2024
2. Best Of ASCO® Vancouver 2024: Special Session: How To Integrate Whole Person Care – Dr. Howard Lim, Dr. Safiya Karim, Prof. Nicole Culos-Reed, Caitlin Wallis, Dr. Carole Richford

   Published: 2/07/2024
3. Best Of ASCO® Vancouver 2024: Gynecological Cancer – Dr. Yvette Drew

   Published: 2/07/2024
4. Best Of ASCO® Vancouver 2024: Lung Cancer – Dr. Randeep Sangha

   Published: 2/07/2024
5. Best Of ASCO® Vancouver 2024: Colorectal GI Cancer – Dr. Sharlene Gill

   Published: 2/07/2024
6. Best Of ASCO® Vancouver 2024: Non-Colorectal GI Cancer – Dr. Hatim Karachiwala

   Published: 2/07/2024
7. Best Of ASCO® Vancouver 2024: Melanoma – Dr. Jose Monzon

   Published: 2/07/2024
8. Best Of ASCO® Vancouver 2024: Lymphoma – Dr. Diego Villa

   Published: 2/07/2024
9. Best Of ASCO® Vancouver 2024: Merck Breakfast Symposium: Clinical Management Of Upper Gastrointestinal (GI) Malignancies In Canada – Dr. Sharlene Gill

   Published: 2/07/2024
10. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: ASC4FIRST STUDY

    Published: 27/06/2024
11. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: SECONDARY-TYPE MUTATIONS IN ELN 2022 FAVORABLE RISK AML & RESULTS FROM THE HARMONY PLATFORM

    Published: 27/06/2024
12. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: GENETIC INSIGHTS INTO ACQUIRED RESISTANCE AND CLONAL EVOLUTION IN VEN-BASED THERAPY FOR AML

    Published: 27/06/2024
13. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: EFFICACY IN NEWLY DIAGNOSED PATIENTS WITH FLT3-ITD+ AML WHO RECEIVED CONTINUATION THERAPY

    Published: 27/06/2024
14. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: REVUMENIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY KMT2AR ACUTE LEUKEMIA

    Published: 27/06/2024
15. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: PHALLCON TRIAL

    Published: 27/06/2024
16. EHA HIGHLIGHTS 2024 - LEUKEMIA ROUNDTABLE DISCUSSION: A COMPARISON OF THE CONSECUTIVE HOVON-100 AND H-146 STUDIES

    Published: 27/06/2024
17. EHA HIGHLIGHTS 2024 - LYMPHOMA ROUNDTABLE DISCUSSION: AN UPDATED ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTY

    Published: 27/06/2024
18. EHA HIGHLIGHTS 2024 - LYMPHOMA ROUNDTABLE DISCUSSION: EPCORE CLL-1 TRIAL

    Published: 27/06/2024
19. EHA HIGHLIGHTS 2024 - LYMPHOMA ROUNDTABLE DISCUSSION: BGB-16673-101 STUDY

    Published: 27/06/2024
20. EHA HIGHLIGHTS 2024 - LYMPHOMA ROUNDTABLE DISCUSSION: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH HEAVILY PRETREATED RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

    Published: 27/06/2024